FDA Investigator LCDR Randall L Morris
LCDR Randall L Morris has conducted inspections on 87 sites in 1 countries as of 13 May 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
87
Last Inspection Date:
13 May 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with LCDR Randall L Morris:
Abraham M Maekele,
Albert A Salvador,
Alec D Fabus,
Alec M O'neal,
Amy Kim,
Andrea H Norwood,
Andrew F Shrake,
Andrew J Mcguffin,
Angela E Glenn,
Annette Melendez,
Ashley A Segura,
Ashley B Jelonek,
Ashley L Reiber,
Barbara T Carmichael,
Betsy C Galliher,
Bill Tacket, Jr,
Bonita S Chester,
Brant M Schroeder,
Brentley S Collins,
Brian D Nicholson,
Brian S Lynch,
Brunilda Torres,
Burnell M Henry,
Byungja E Marciante,
Carla A Norris,
Carol S Davis,
Carrie Ann Plucinski,
CDR Ileana Barreto Pettit,
Chad R Burger,
Cheryl L Watson,
Christopher J Adams,
Claire M Minden,
Cody D Rickman,
Courtney A Gilbert,
Courtney A Hunt,
Craig A Garmendia,
Cynthia L Medlin,
David Perkins,
Deborah A Racioppi,
Deborah M Trout,
Debra I Love,
Diane L Kelsch,
Dillard H Woody, Jr,
Donald J Mee,
Donna D Gallien, MPH,
Dwayne E Dollins,
Edward A Brunt,
Eliezar Ramos,
Elizabeth D Connell,
Elizabeth W Ormond,
Emily A Baldwin,
Emily E Smith,
Emily S Baldwin,
Ernest A Clausnitzer,
Ethan P Stegman,
Fabian Nchaparro Rodriguez,
Gabriel E Muniz,
Gene D Arcy,
Gene R Gunn,
Glenn S Quintanilla,
Gregory Price,
Heather M Bullock,
Helen B Ricalde,
Holly M Scott,
Humera T Khan,
Israel Juarbe,
Jacqueline Mdiaz Albertini,
Jana L Caylor,
Jason D Abel,
Jason D Tenney,
Jason F Chancey,
Jason P Aun,
Jeanne M Morris,
Jennifer L Schmidt,
Jennifer Lalama,
Jennifer M Menendez,
Jessica L Pressley,
Joan A Loreng,
Joanne E King,
John B Crowe,
John Godshalk,
John M Seale,
Jolanna A Norton,
Jose N Santiago,
Jose R Rodriguez,
Joshua J Silvestri,
Justin A Boyd,
Karen Gale Sego,
Karissa J Mccaw,
Kelly I Anderson,
Kenneth R Merritt,
Konsuela Y Glass,
Lacey J Chessor,
Ladislav Kermet,
Laressa R Gray,
Latrice G Jones,
Laura E Garcia,
Laura Fontan, MS,
LCDR Angelica M Chica,
LCDR Debra Emerson,
Leslie A Cartmill,
Lindsay R Hatch,
Lindsay R Mundy,
Lisa A Warner,
LT Kimberly M Hull,
Lura D Baquero,
Lura D Kelly,
Madelyn Renteria,
Marion Michaelis,
Matthew B Thomaston,
Megan K Otero,
Melanie L Drayton,
Melinda B Lewis,
Melissa J Hill,
Mercy O Quagraine,
Meredith M Andress,
Meredith M Cobb,
Michael T Nehring,
Mihaly S Ligmond,
Mizanne E Lewis,
Mohammad Heidaran, PhD,
Myra K Casey,
Nancy L Meade,
Nancy L Neiger,
Nelson E Venerio,
Nicolas Riveratorres,
Nicole E Knowlton,
Nicole M Bell,
Omotunde O Osunsanmi,
Ormond,
Pete Amin (Pankaj),
Prabhu P Raju,
Randy L Clarida,
Reynolds,
Richard Heath Coats,
Richard J Bashay,
Richard K Vogel,
Richard T Riggie,
Robert W Calais,
Ronnie E Jackson,
Russell K Riley,
Ruth A Williams,
Salvatore N Randazzo,
Samantha J Pinizzotto, D V M,
Samuel W Labinjo,
Saundrea A Munroe,
Sherbet L Samuels,
Sheri L Stephenson,
Simone E Pitts,
Sonia M Monges,
Stacey F Allard,
Stacey F Rivette,
Stephanie C Milan,
Stephen D Brown,
Susan M Jackson,
Susan P Bruederle,
Teresa M Hillebrandt,
Thai D Truong,
Tiana M Mckinley,
Traci M Armand,
Tracy L Reed,
Unnee Ranjan,
Valerie Jgrecek Trinh,
William A Oetting,
Woody,
Yonggang Wang, PhD
LCDR Randall L Morris's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| November, 2012 | FDA 483 | Diomedics Light Therapy, Inc. - Form 483, 2012-11-06 |
| August, 2015 | EIR | Carlos Danger, M.D. - EIR, 2015-08-21 |
| July, 2013 | FDA 483 | Wells Pharmacy Network LLC - Form 483, 2013-07-26 |
| May, 2012 | FDA 483 | Wells Pharmacy Network LLC - Form 483, 2012-05-11 |
| September, 2010 | FDA 483 | OneBlood, Inc. - Form 483, 2010-09-24 |
| May, 2019 | FDA 483 | CSL Behring L.L.C. - Form 483, 2019-05-23 |
| August, 2009 | EIR | CB Manufacturing Company Inc. - EIR, 2009-08-11 |
| May, 2010 | FDA 483 | Rajiv Chandra, M.D., Clinical Investigator - Form 483, 2010-05-24 |
| August, 2015 | FDA 483 Response | Carlos Danger, M.D. - Form 483R, 2015-08-21 |
| April, 2014 | EIR | Linda S. Harper, M.D. - EIR, 2014-04-14 |
| August, 2015 | FDA 483 | Carlos Danger, M.D. - Form 483, 2015-08-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more